VAXCYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.00 USD | +1.64% |
|
+3.96% | +84.71% |
| 10/09 | Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree... |  |
| 10/09 | Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VAXCYTE, INC. | Bio Therapeutic Drugs | +1.64% | +3.96% | +84.71% | +125.24% | - | 1.43TCr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition